Patent · US Active

Aryl substituted pyrimidines for use in influenza virus infection

US11117887B2 · kind B2 · utility

0Cited by

6References

17Claims

0Family size

Assignee

Janssen Sciences Ireland Unlimited Company · IE

Inventors

Tim Hugo Maria Jonckers · Heist-op-den-Berg, BE
David Craig McGowan · Vilvoorde, BE
Jérôme Emile Georges Guillemont · Andé, FR
Werner Constant Johan Embrechts · Beerse, BE
Guillaume Jean Maurice Mercey · Issy-les-Moulineaux, FR
Christophe Francis Robert Nestor Buyck · Temse, BE
Wendy Mia Albert Balemans · Kalmthout, BE
Pierre Jean-Marie Bernard Raboisson · Sligo, IE

Key dates

Filing date	Apr 3, 2020
Grant date	Sep 14, 2021
Priority date	—
Expiry date	Apr 3, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D513/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to compounds having the structure of formula (I) which can be used for the treatment of or against influenza infections.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.